Sfoglia per Autore
iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cells
2009-01-01 De Boo S; Kopecka J; Brusa D; Gazzano E; Matera L; Ghigo D; Bosia A; Riganti C.
Liposomal doxorubicin reverses drug-resistance by inhibiting P-glycoprotein in human cancer cells
2010-01-01 I. Campia; C. Riganti; C. Voena; J. Kopecka; E. Enrico; C. Costamagna; D. Ghigo; A. Bosia
Modulation of doxorubicin resistance by the glucose 6-phosphate dehydrogenase activity
2011-01-01 M. Polimeni; C. Voena; J. Kopecka; C. Riganti; G. Pescarmona; A. Bosia; D. Ghigo
Digoxin and oubain increase the synthesis of cholesterol in human liver cells
2011-01-01 Joanna Kopecka; Ivana Campia; Amalia Bosia; Chiara Riganti
Modulation of doxorubicin resistance by the glucose 6-phosphate dehydrogenase activity
2011-01-01 M. Polimeni; C. Voena; J. Kopecka; C. Riganti; G. Pescarmona; A. Bosia; D. Ghigo
Pleiotropic Effects of Cardioactive Glycosides.
2011-01-01 Riganti C; Campia I; Kopecka J; Gazzano E; Doublier S; Aldieri E; Bosia A; Ghigo D
A LDL-masked liposomal-doxorubicin reverses drug resistance in human cancer cells
2011-01-01 Kopecka J; Campia I; Olivero P; Pescarmona GP; Ghigo D; Bosia A; Riganti C
Liposome-encapsulated doxorubicin reverses drug resistance by inhibiting P-glycoprotein in human cancer cells.
2011-01-01 Riganti C; Voena C; Kopecka J; Corsetto PA; Montorfano G; Enrico E; Costamagna C; Rizzo AM; Ghigo D; Bosia A
Modulation of doxorubicin resistance by the glucose 6-phosphate dehydrogenase activity
2011-01-01 Manuela Polimeni; Claudia Voena; Johanna Kopecka; Chiara Riganti; Gianpiero Pescarmona; Amalia Bosia; Dario Ghigo
Modulation of doxorubicin resistance by the glucose 6-phosphate dehydrogenase activity
2011-01-01 Polimeni M; Voena C; Kopecka J; Riganti C; Pescarmona G; Bosia A; Ghigo D
Nitric oxide and P-glycoprotein modulate the phagocytosis of colon cancer cells
2011-01-01 Kopecka J; Campia I; Brusa D; Doublier S; Matera L; Ghigo D; Bosia A; Riganti C
Zoledronic acid restores doxorubicin chemosensitivity and immunogenic cell death in multidrug-resistant human cancer cells
2012-01-01 I. Campia; J. Kopecka; B. Castella; M. Rigoni; M. Coscia; A. Bosia; D. Ghigo; M. Massaia; C. Riganti
Cardiac glycosides as new modulators of cholesterol metabolism
2012-01-01 I. Campia; V. Sala; J. Kopecka; C. Leo; N. Mitro; C. Costamagna; D. Caruso; G. Pescarmona;T. Crepaldi; D. Ghigo; A. Bosia; C. Riganti
Targeting mevalonate pathway down-regulates ABCB1, reversing chemoresistance and immunoresistance in human cancer cells.
2012-01-01 Joanna Kopecka; Ivana Campia; Barbara Castella; Massimo Massaia; Chiara Riganti
Pleiotropic effects of liposomal nanoparticles on ABCB1 in cancer cells
2012-01-01 I. Campia ; J.Kopecka; M.L. Pinzon; D. Ghigo; C. Riganti
Cardioactive glycosides induce the efflux of cholesterol by upregulating ABCA1
2012-01-01 I. Campia; J. Kopecka ;G. Pescarmona; D. Ghigo ; C. Riganti
Temozolomide epigenetically down-regulates Wnt3a-dependent signaling and P- glycoprotein in glioblastoma stem cells
2012-01-01 I. Campia; I.C. Salaroglio; J. Kopecka; M.L. Pinzòn; V. Caldera; D. Ghigo; A. Bosia; D. Schiffer; C. Riganti
Digoxin and ouabain induce the efflux of cholesterol via LXR signalling and the synthesis of ATP in cardiomyocytes.
2012-01-01 Campia I; Sala V; Kopecka J; Leo C; Mitro N; Costamagna C; Caruso D; Pescarmona G; Crepaldi T; Ghigo D; Bosia A; Riganti C.
Mitochondrial-targeting nitrooxy-doxorubicin: a new approach to overcome drug resistance.
2013-01-01 Chiara Riganti; Barbara Rolando; Joanna Kopecka; Ivana Campia; Konstantin Chegaev; Loretta Lazzarato; Antonella Federico; Roberta Fruttero; Dario Ghigo
Nitrooxy-doxorubicin: A New Weapon Against Multidrug Resistance.
2013-01-01 Joanna Kopecka; Chiara Riganti; Barbara Rolando; Ivana Campia; Konstantin Chegaev; Loretta Lazzarato; Antonella Federico; Roberta Fruttero; Dario Ghigo
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
iNOS activity is necessary for the cytotoxic and immunogenic effects of doxorubicin in human colon cancer cells | 2009 | De Boo S; Kopecka J; Brusa D; Gazzano E; Matera L; Ghigo D; Bosia A; Riganti C. | |
Liposomal doxorubicin reverses drug-resistance by inhibiting P-glycoprotein in human cancer cells | 2010 | I. Campia; C. Riganti; C. Voena; J. Kopecka; E. Enrico; C. Costamagna; D. Ghigo; A. Bosia | |
Modulation of doxorubicin resistance by the glucose 6-phosphate dehydrogenase activity | 2011 | M. Polimeni; C. Voena; J. Kopecka; C. Riganti; G. Pescarmona; A. Bosia; D. Ghigo | |
Digoxin and oubain increase the synthesis of cholesterol in human liver cells | 2011 | Joanna Kopecka; Ivana Campia; Amalia Bosia; Chiara Riganti | |
Modulation of doxorubicin resistance by the glucose 6-phosphate dehydrogenase activity | 2011 | M. Polimeni; C. Voena; J. Kopecka; C. Riganti; G. Pescarmona; A. Bosia; D. Ghigo | |
Pleiotropic Effects of Cardioactive Glycosides. | 2011 | Riganti C; Campia I; Kopecka J; Gazzano E; Doublier S; Aldieri E; Bosia A; Ghigo D | |
A LDL-masked liposomal-doxorubicin reverses drug resistance in human cancer cells | 2011 | Kopecka J; Campia I; Olivero P; Pescarmona GP; Ghigo D; Bosia A; Riganti C | |
Liposome-encapsulated doxorubicin reverses drug resistance by inhibiting P-glycoprotein in human cancer cells. | 2011 | Riganti C; Voena C; Kopecka J; Corsetto PA; Montorfano G; Enrico E; Costamagna C; Rizzo AM; Ghigo D; Bosia A | |
Modulation of doxorubicin resistance by the glucose 6-phosphate dehydrogenase activity | 2011 | Manuela Polimeni; Claudia Voena; Johanna Kopecka; Chiara Riganti; Gianpiero Pescarmona; Amalia Bosia; Dario Ghigo | |
Modulation of doxorubicin resistance by the glucose 6-phosphate dehydrogenase activity | 2011 | Polimeni M; Voena C; Kopecka J; Riganti C; Pescarmona G; Bosia A; Ghigo D | |
Nitric oxide and P-glycoprotein modulate the phagocytosis of colon cancer cells | 2011 | Kopecka J; Campia I; Brusa D; Doublier S; Matera L; Ghigo D; Bosia A; Riganti C | |
Zoledronic acid restores doxorubicin chemosensitivity and immunogenic cell death in multidrug-resistant human cancer cells | 2012 | I. Campia; J. Kopecka; B. Castella; M. Rigoni; M. Coscia; A. Bosia; D. Ghigo; M. Massaia; C. Riganti | |
Cardiac glycosides as new modulators of cholesterol metabolism | 2012 | I. Campia; V. Sala; J. Kopecka; C. Leo; N. Mitro; C. Costamagna; D. Caruso; G. Pescarmona;T. Crepaldi; D. Ghigo; A. Bosia; C. Riganti | |
Targeting mevalonate pathway down-regulates ABCB1, reversing chemoresistance and immunoresistance in human cancer cells. | 2012 | Joanna Kopecka; Ivana Campia; Barbara Castella; Massimo Massaia; Chiara Riganti | |
Pleiotropic effects of liposomal nanoparticles on ABCB1 in cancer cells | 2012 | I. Campia ; J.Kopecka; M.L. Pinzon; D. Ghigo; C. Riganti | |
Cardioactive glycosides induce the efflux of cholesterol by upregulating ABCA1 | 2012 | I. Campia; J. Kopecka ;G. Pescarmona; D. Ghigo ; C. Riganti | |
Temozolomide epigenetically down-regulates Wnt3a-dependent signaling and P- glycoprotein in glioblastoma stem cells | 2012 | I. Campia; I.C. Salaroglio; J. Kopecka; M.L. Pinzòn; V. Caldera; D. Ghigo; A. Bosia; D. Schiffer; C. Riganti | |
Digoxin and ouabain induce the efflux of cholesterol via LXR signalling and the synthesis of ATP in cardiomyocytes. | 2012 | Campia I; Sala V; Kopecka J; Leo C; Mitro N; Costamagna C; Caruso D; Pescarmona G; Crepaldi T; Ghigo D; Bosia A; Riganti C. | |
Mitochondrial-targeting nitrooxy-doxorubicin: a new approach to overcome drug resistance. | 2013 | Chiara Riganti; Barbara Rolando; Joanna Kopecka; Ivana Campia; Konstantin Chegaev; Loretta Lazzarato; Antonella Federico; Roberta Fruttero; Dario Ghigo | |
Nitrooxy-doxorubicin: A New Weapon Against Multidrug Resistance. | 2013 | Joanna Kopecka; Chiara Riganti; Barbara Rolando; Ivana Campia; Konstantin Chegaev; Loretta Lazzarato; Antonella Federico; Roberta Fruttero; Dario Ghigo |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile